Navigation Links
ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
Date:10/20/2008

the newly created position of vice president, clinical and development programs where his primary responsibility is the leadership and co-ordination of development activities within the NDA/MAA/NDS submission team for maribavir, ViroPharma's anti-cytomegalovirus compound. He has 17 years of industry and academic experience in the area of infectious diseases and antimicrobials clinical research. Prior to joining ViroPharma in 2005, Dr. Gelone was the director of the medical science liaison team and led publications strategy for Vicuron Pharmaceuticals. From 2001 to 2002, he was director of clinical pharmacology and discovery medicine in antimicrobial drug discovery for GlaxoSmithKline. Dr. Gelone has held numerous academic appointments at Temple University, including director of clinical research, director of residency and fellowship programs (School of Pharmacy), adjunct associate professor in the division of infectious diseases, senior research fellow and steering committee member for the General Clinical Research Center (School of Medicine). He is currently an associate professor of community medicine and preventive health at Drexel University College of Medicine, and associate professor of pharmacy with tenure at the Temple University School of Pharmacy. Dr. Gelone holds both a Bachelors of Science in Pharmacy and a Doctor of Pharmacy degree from the Temple University School of Pharmacy.

Glenn S. Tillotson, Ph.D., FRSM, FCCP, has joined ViroPharma as head of medical affairs where he will be responsible to lead the medical affairs team providing medical leadership to disease-specific strategy to support optimal positioning of marketed and development products. Prior to joining ViroPharma, Dr. Tillotson was most recently Executive Director of Scientific Affairs at Replidyne. Dr. Tillotson brings to ViroPharma over 20 years pharmaceutical industry experience in numerous areas including clinical research, marketing, scientific communications, strategic develo
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. ViroPharma to Present at Two Upcoming Healthcare Conferences
2. ViroPharma Provides 2008 Outlook
3. ViroPharma to Present at the BIO CEO & Investor Conference
4. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
7. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
8. ViroPharma to Present at Two Upcoming Healthcare Conferences
9. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
10. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
11. ViroPharma To Acquire Lev Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com ... available in its catalogue: Global Chelating ... About Chelating Agent A chelating ... covalent bonds with metal ions, thereby forming a ... some metal-ions have on chemical processes, formulations, and ...
(Date:8/27/2014)... Aug. 27, 2014  A novel biomarker for ... physicians better identify early-stage disease, when treatment can ... to a new study in The Journal of ... DGX ) and other institutions found ... outperformed conventional antibody-serum testing, including rheumatoid factor (RF) ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com has ... The Graphene Opportunity - A Rational View ... The New Nanotech? A similar amount of ... applications ranging from microelectronics to water treatment, but ... the availability of the Graphene Opportunity Report, authored ...
(Date:8/27/2014)... Research and Markets  has announced the ... Spectrometer Industry Report 2014" report to their offering. ... Spectrometer Industry Report 2014 is a professional and in-depth ... ratio mass spectrometer industry. The report provides ... applications and industry chain structure. The isotope ratio mass ...
Breaking Biology Technology:Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 2Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 3Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study 4The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2
... TRIANGLE PARK, N.C., Nov. 17, 2010 Chimerix, Inc., ... an update to the World Health Organization (WHO) on ... at the 12th Meeting of the WHO Advisory Committee ... of CMX001 for Smallpox and Other dsDNA Viruses."  CMX001 ...
... SEATTLE, Nov. 17, 2010 Cell Therapeutics, Inc. ("CTI") ... Medicines Agency ("EMA") approved CTI,s Pixuvri (pixantrone dimaleate) Pediatric ... and solid tumors in children between the ages of ... (the "PDCO") of the EMA adopted an opinion agreeing ...
... Researchers have demonstrated a new imaging tool for ... hastening their use in creating a new class ... consume less power than today,s. The semiconducting ... replacing conventional silicon components and circuits. However, one ...
Cached Biology Technology:Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research 2Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research 3European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri 2European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri 3Imaging tool may aid nanoelectronics by screening tiny tubes 2Imaging tool may aid nanoelectronics by screening tiny tubes 3
(Date:8/27/2014)... invasive grass species frequently found in forests has created ... on American toads, a new University of Georgia study ... to the U.S. in the early 1900s, is one ... to more than a dozen states in the past ... and in forests, it can survive in widely diverse ...
(Date:8/27/2014)... Africa is entering what is described by the Volunteer ... The Eastern Cape provincial government warned residents in ... strong winds and veld fires. A high veld ... and along the coast in the Great Kei and ... regions, and during thunderstorms. The thunderstorms bring lightning ...
(Date:8/27/2014)... that exists as five strains, none of which have ... the Sudan ebolavirus (SUDV). Although not the strain currently ... as recently as 2012. In a new study appearing ... now report a possible therapy that could someday help ... Sidhu, Jonathan Lai and colleagues explain that about 50-90 ...
Breaking Biology News(10 mins):More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2
... of British Columbia and the Child & Family Research Institute ... a type of T cell in type 1 diabetes that ... Also known as juvenile diabetes, type 1 diabetes is an ... with type 1 diabetes, the body attacks itself by destroying ...
... to the National Heart, Lung and Blood Institute, the average ... and 30 times a night. This lack of oxygen leads ... disease, an abnormal heart rhythm, or even a fatal cardiac ... exploring the changes in distinct brain regions that contribute to ...
... The National Institute of Environmental Health Sciences has ... Shaw for a five-year study of how the ... selection. The project reflects a changing ... advances in molecular toxicology, computational sciences and information ...
Cached Biology News:Researchers study sleep apnea and lack of oxygen 2Researcher awarded $2.27 million to study environmental effects on gene copy number 2Researcher awarded $2.27 million to study environmental effects on gene copy number 3Researcher awarded $2.27 million to study environmental effects on gene copy number 4
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
ID clarifier: With ethidium bromide (50 μg/ml)...
... in DMEM and harvested at the log phase ... antigens in their native forms, cells were fixed ... a 12-well (5 mm) adhesive coated slide, with ... attachment and to minimize background staining. Each ...
Biology Products: